aldosterone has been researched along with ramipril in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (16.67) | 18.7374 |
| 1990's | 8 (26.67) | 18.2507 |
| 2000's | 13 (43.33) | 29.6817 |
| 2010's | 3 (10.00) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brockmeier, D; Heintz, B; Kierdorf, H; Kirsten, R; Lückel, G; Maigatter, S; Nelson, K; Rangoonwala, B; Sieberth, HG; Verho, M | 1 |
| Bainbridge, AD; Lees, KR; MacFadyen, RJ; Reid, JL | 1 |
| Baldes, L; Becker, RH; Treudler, M | 1 |
| Debusmann, ER; Grötsch, H; Irmisch, R; Jane, F; Lahn, W; Mora, J; Ocón-Pujadas, J | 1 |
| Böhm, RO; Rahn, KH; van Baak, MA | 1 |
| Distler, A; Eckert, HG; Haller, H; Irmisch, R; Lenz, T; Metzger, H; Meyer-Sabellek, W; Philipp, T; Tansey, MJ; Wilp, C | 1 |
| Eckert, HG; Irmisch, R; Metzger, H; Witte, PU | 1 |
| Amtorp, O; Gundersen, T; Nilsson, B; Remes, J; Sigurdsson, A; Swedberg, K | 1 |
| Cervenka, JH; Kailasam, MT; Kennedy, BP; O'Connor, DT; Parmer, RJ; Wu, RA; Ziegler, MG | 1 |
| Sigurdsson, A; Swedberg, K; Ullman, B | 1 |
| Barthelmebs, M; Grima, M; Imbs, J; Stephan, D; Vasmant, D; Welsch, M | 1 |
| Bech, JN; Hansen, HE; Jensen, KT; Kornerup, HJ; Nielsen, CB; Pedersen, EB; Spencer, ES; Sølling, J | 1 |
| Batlle, D; Danesh, FR; Keilani, T; Molteni, A; Schlueter, WA | 1 |
| Redfield, MM | 1 |
| Ditiatkov, AE; Radzevich, AE; Tikhonov, VA | 1 |
| Abbas, A; Brown, NJ; Byrne, D; Schoenhard, JA; Vaughan, DE | 1 |
| Agabiti-Rosei, E; Bova, S; Cavallin, M; Mazzocchi, G; Nussdorfer, GG; Pessina, AC; Rizzoni, D; Rossi, GP | 1 |
| Bergmann, JF; Caulin, C; Cohen-Solal, A; Habib, A; Jondeau, G; Kevorkian, JP; Knellwolf, AL; Lebret, M; Levy, B; Mahé, I; Meune, C; Mourad, JJ; Simoneau, G | 1 |
| Aviram, M; Coleman, R; Hamoud, S; Hayek, T; Kaplan, M; Keidar, S; Pavlotzky, E | 1 |
| Andreucci, M; Caglioti, A; Cianfrone, P; Comi, N; Fuiano, G; Fuiano, L; Mancuso, D; Marino, F; Mazza, G; Zamboli, P | 1 |
| Brown, NJ; Davis, SN; Muldowney, JA; Vaughan, DE | 1 |
| de Champlain, J; Karas, M; Lacourcière, Y; Lamarre-Cliche, M; Larochelle, P; Poirier, L | 1 |
| Alhenc-Gelas, F; Ankotche, A; Bouhanick, B; Chatellier, G; Gallois, Y; Hadjadj, S; Lefebvre, PJ; Marre, M; Pean, F; Roussel, R; Weekers, L | 1 |
| Azizi, M; Bissery, A; Floch, A; Guyene, TT; Ménard, J; Ozoux, ML; Peyrard, S | 1 |
| Brown, NJ; Muldowney, JA; Vaughan, DE | 1 |
| Bobillier, A; Gardner, R; Hillier, C; MacFadyen, R; Mann, J; McDonagh, T; McMurray, J; Murdoch, D; Seed, A | 1 |
| de Boer, IH; Pichler, RH | 1 |
| Derosa, G; Fogari, R; Maffioli, P; Mugellini, A; Perrone, T; Preti, P; Zoppi, A | 1 |
| Azizi, M; Bobrie, G; Chatellier, G; Frank, M; Ménard, J; Perdrix, L; Plouin, PF | 1 |
| Funder, JW | 1 |
1 review(s) available for aldosterone and ramipril
| Article | Year |
|---|---|
Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease.
Topics: Albuminuria; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Benzimidazoles; Benzoates; Diabetic Nephropathies; Humans; Hyperkalemia; Models, Biological; Ramipril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan | 2010 |
16 trial(s) available for aldosterone and ramipril
| Article | Year |
|---|---|
Influence of ramipril on plasma atrial natriuretic peptide, antidiuretic hormone, angiotensin II and aldosterone in patients with chronic congestive heart failure.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Female; Heart Failure; Humans; Male; Middle Aged; Radioimmunoassay; Ramipril; Sodium; Vasopressins | 1992 |
A study of the acute pharmacodynamic interaction of ramipril and felodipine in normotensive subjects.
Topics: Adult; Aldosterone; Blood Pressure; Bridged Bicyclo Compounds; Double-Blind Method; Drug Interactions; Electrolytes; Felodipine; Heart Rate; Humans; Male; Norepinephrine; Peptidyl-Dipeptidase A; Ramipril; Random Allocation; Renin | 1991 |
Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Double-Blind Method; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Peptidyl-Dipeptidase A; Prognosis; Ramipril; Time Factors | 1994 |
Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?
Topics: Aldosterone; Autonomic Nervous System; Blood Pressure; Catecholamines; Cold Temperature; Cross-Over Studies; Double-Blind Method; Enalapril; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Ramipril; Renin | 1994 |
Effects of ramipril on the neurohormonal response to exercise in patients with mild or moderate congestive heart failure.
Topics: Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Double-Blind Method; Exercise Test; Female; Heart Failure; Hemodynamics; Hormones; Humans; Male; Middle Aged; Norepinephrine; Prospective Studies; Ramipril | 1994 |
Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
Topics: Aldosterone; Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Male; Peptidyl-Dipeptidase A; Potassium; Ramipril; Renin; Renin-Angiotensin System | 1996 |
A comparison of the effect of ramipril, felodipine and placebo on glomerular filtration rate, albuminuria, blood pressure and vasoactive hormones in chronic glomerulonephritis. A randomized, prospective, double-blind, placebo-controlled study over two yea
Topics: Adolescent; Adult; Aged; Albuminuria; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Endothelins; Felodipine; Female; Glomerular Filtration Rate; Glomerulonephritis; Humans; Male; Middle Aged; Placebos; Prospective Studies; Ramipril | 1997 |
A subdepressor low dose of ramipril lowers urinary protein excretion without increasing plasma potassium.
Topics: Adult; Aged; Aldosterone; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Drug Administration Schedule; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peptidyl-Dipeptidase A; Potassium; Proteinuria; Ramipril; Renin; Treatment Outcome | 1999 |
Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiovascular Diseases; Cross-Over Studies; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Postmenopause; Ramipril; Renin; Single-Blind Method; Tissue Plasminogen Activator | 2002 |
NO synthase inhibition increases aldosterone in humans.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Arginine; Double-Blind Method; Enzyme Inhibitors; Female; Hemodynamics; Humans; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Potassium; Ramipril; Renin | 2004 |
Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.
Topics: Adult; Aged; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Calcium Channel Blockers; Circadian Rhythm; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Posture; Prospective Studies; Ramipril; Reference Values; Renin; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2005 |
Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biotransformation; Biphenyl Compounds; Cross-Over Studies; Cyclic GMP; Dose-Response Relationship, Drug; Heterocyclic Compounds, 3-Ring; Humans; Irbesartan; Male; Natriuresis; Oligopeptides; Peptidyl-Dipeptidase A; Protease Inhibitors; Ramipril; Renin; Renin-Angiotensin System; Single-Blind Method; Tetrazoles | 2006 |
Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Arginine; Double-Blind Method; Drug Combinations; Enzyme Inhibitors; Female; Fibrinolysis; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Plasminogen Activator Inhibitor 1; Prodrugs; Ramipril; Reference Values; Renin-Angiotensin System | 2006 |
Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure.
Topics: Aged; Aldosterone; Amides; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Fumarates; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Ramipril; Renin; Statistics, Nonparametric; Treatment Outcome | 2007 |
Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria.
Topics: Adult; Aged; Albumins; Albuminuria; Aldosterone; Amides; Antihypertensive Agents; Arterial Pressure; Biomarkers; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fumarates; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Ramipril; Renin; Single-Blind Method; Treatment Outcome | 2013 |
Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension.
Topics: Adolescent; Adult; Aged; Aldosterone; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Bisoprolol; Blood Pressure; Blood Pressure Determination; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Ramipril; Renin; Renin-Angiotensin System; Spironolactone; Tetrazoles; Young Adult | 2014 |
13 other study(ies) available for aldosterone and ramipril
| Article | Year |
|---|---|
Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Diuretics; Electrolytes; Furosemide; Heart Rate; Hypertension; Male; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Inbred SHR; Renin; Sulfonamides | 1989 |
Pharmacodynamic effects of a single 10-mg dose of the angiotensin converting enzyme inhibitor ramipril in patients with impaired renal function.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Creatinine; Female; Heart Rate; Humans; Kidney Diseases; Male; Middle Aged; Peptidyl-Dipeptidase A; Ramipril; Renin; Time Factors | 1989 |
Studies on the antihypertensive effect of single doses of the angiotensin converting enzyme inhibitor ramipril (HOE 498) in man.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Ramipril; Renin-Angiotensin System | 1986 |
Humoral and blood pressure effects of the angiotensin converting enzyme inhibitor ramipril in essential hypertension.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Humans; Hypertension; Kinetics; Male; Middle Aged; Ramipril; Renin | 1986 |
Tolerance and pharmacodynamics of the angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in healthy volunteers.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Female; Heart Rate; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Potassium; Ramipril; Renin; Sodium; Time Factors | 1984 |
Epidemiology and pathophysiology of heart failure.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Disease Progression; Heart Failure; Humans; Incidence; Pulse; Ramipril; Spironolactone; Survival Analysis; Ventricular Function, Left | 2000 |
[Activity of the renin-angiotensin-aldosterone system and its impact on the effectiveness of treatment of chronic heart failure in patients with pulmonary tuberculosis].
Topics: Aldosterone; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Heart Failure; Humans; Radioimmunoassay; Ramipril; Renin; Renin-Angiotensin System; Tuberculosis, Pulmonary | 2001 |
Dual ACE and NEP inhibitor MDL-100,240 prevents and regresses severe angiotensin II-dependent hypertension partially through bradykinin type 2 receptor.
Topics: Adrenomedullin; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Benzazepines; Biomarkers; Blood Pressure; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Heart; Hypertension; Male; Models, Cardiovascular; Neprilysin; Organ Size; Peptides; Pyridines; Ramipril; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Receptors, Bradykinin; Severity of Illness Index; Systole; Treatment Outcome; Vasoconstrictor Agents | 2002 |
Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Arteries; Aspirin; Blood Pressure; Chronic Disease; Controlled Clinical Trials as Topic; Cyclooxygenase Inhibitors; Diastole; Dose-Response Relationship, Drug; Enalapril; Endpoint Determination; Female; Heart Failure; Heart Rate; Humans; Lisinopril; Male; Manometry; Middle Aged; Observer Variation; Prospective Studies; Ramipril; Renin; Reproducibility of Results; Single-Blind Method; Systole; Thromboxane B2; Time Factors; Treatment Outcome | 2003 |
Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cell Line; Enzyme Induction; Eplerenone; Hormone Antagonists; Humans; Lipid Peroxidation; Lipoproteins, LDL; Losartan; Macrophages, Peritoneal; Membrane Proteins; Mice; Mice, Knockout; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Oxidative Stress; Peptidyl-Dipeptidase A; Phosphoproteins; Protein Transport; Ramipril; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Superoxides | 2004 |
Can young adult patients with proteinuric IgA nephropathy perform physical exercise?
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Creatinine; Disease Progression; Exercise Test; Exercise Tolerance; Female; Glomerulonephritis, IGA; Hematuria; Humans; Kidney Tubules, Proximal; Male; Proteinuria; Ramipril; Renin | 2004 |
Modulation of the renal response to ACE inhibition by ACE insertion/deletion polymorphism during hyperglycemia in normotensive, normoalbuminuric type 1 diabetic patients.
Topics: Adult; Albuminuria; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 1; Female; Gene Deletion; Genotype; Glomerular Filtration Rate; Hemodynamics; Humans; Hyperglycemia; Kidney; Male; Mutagenesis, Insertional; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Ramipril; Renin | 2005 |
Primary Aldosteronism: The Next Decade.
Topics: Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertension; Ramipril; Renin | 2020 |